文献速递免疫规划卫生政策与健康促进

日本与美国免疫体系比较及启示

Comparison of immunization systems in Japan and the United States - What can be learned?
PubMed 文献 · Vaccine · 2020-09-29

本文回顾导致日本现行免疫体系的关键历史事件,并与美国体系进行比较,讨论改进策略。2013年人乳头瘤病毒疫苗(HPVV)不良事件报告后日本政府撤回积极推荐,HPVV覆盖率骤降至不足1.0%。通过强化国家免疫技术咨询小组、不良事件报告、补偿法律和免疫教育等现有政策与项目,可填补日本剩余的疫苗差距。

要点

  • 2013年HPVV不良事件报告致日本撤回积极推荐,覆盖率降至不足1.0%。
  • 对免疫后不良事件(AEFI)的担忧使日本国家免疫规划(NIP)政策制定趋于被动。
  • 强化国家免疫技术咨询小组、AEFI报告、补偿法律和免疫教育可填补疫苗差距。

核心结论

  • 通过强化现有政策与项目,可填补日本剩余的疫苗差距。

研究设计与样本

  • 本文为综述,回顾导致日本现行免疫体系的关键历史事件并与美国体系比较。

主要发现

  • 2013年HPVV不良事件报告后日本政府撤回积极推荐,HPVV覆盖率骤降至不足1.0%。
  • 对AEFI的担忧导致日本NIP政策制定历史上趋于被动。

关键数值与推荐

  • HPVV覆盖率降至不足1.0%。

临床怎么用

  • 可强化国家免疫技术咨询小组、AEFI报告、补偿法律和免疫教育以改进免疫体系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recently, efforts have been made to fill a so-called "vaccine gap" between Japan and other countries; however, more work remains. Concerns about adverse events following immunization (AEFI) resulted in an historically passive approach to policy making in the National Immunization Program (NIP). For example, reports of AEFI following human papillomavirus vaccine (HPVV) in 2013 led the Japanese government to withdraw its proactive recommendations, resulting in a sharp drop in HPVV coverage rate to less than 1.0%. In this report, we review key historical incidents that led to the current immunization system in Japan, compare it to that in the United States, and discuss strategies for improving the Japanese immunization system. By strengthening existing policies and programs, such as National Immunization Technical Advisory Groups and AEFI reporting, compensation laws, and immunization education, the remaining vaccine gap in Japan could be filled.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Katsuta T, Moser CA, Feemster KA, et al. Comparison of immunization systems in Japan and the United States - What can be learned? Vaccine. 2020. PMID: 33004240. doi:10.1016/j.vaccine.2020.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。